Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063253927> ?p ?o ?g. }
- W2063253927 endingPage "2735" @default.
- W2063253927 startingPage "2728" @default.
- W2063253927 abstract "Adenosine deaminase (ADA) and carcinoembryonic antigen (CEA) have been measured in pleural fluid to help distinguish malignant from benign effusions, especially in tuberculous pleurisy. We investigated ADA and CEA levels in patients with moderate to large pericardial effusions of different etiologies.We performed diagnostic and therapeutic pericardiostomy with drainage and biopsy. We measured ADA and CEA levels in the pericardial fluid in 26 patients with moderate to large pericardial effusion and 19 control patients. Patients were included in a prospective protocol from August 1991 to August 1993. Patients were grouped as follows: group 1, 9 patients with tuberculous pericarditis (TP) confirmed by bacteriologic culture or histology of pericardial biopsy; group 2, 5 patients with clinically strongly suspected TP; group 3, 12 patients with malignancy (8) and acute pericarditis (4); group 4, 19 control patients without pericardial disease. We treated patients with TP with isoniazid, rifampin, and either streptomycin or ethambutol for 12 months and pyrazinamide for 2 months. We observed for symptoms and signs of recurrent pericarditis or constrictive pericarditis on follow-up. In group 1 the ADA activity was significantly higher (101 +/- 14 U/L) than that in group 3 (22 +/- 5 U/L) or that in group 4 (17 +/- 2 U/L) (P < .05). There was no significant difference between ADA activity in group 1 (101 +/- 14 U/L) and that in group 2 (100 +/- 26 U/L). With a cutoff value for ADA activity of 40 U/L, sensitivity was 93% and specificity 97% in the diagnosis of TP. In benign diseases, the CEA level was significantly lower (1.0 +/- 0.3 ng/mL) than that in malignant diseases (135.1 +/- 79.7 ng/mL) (P < .05). With a cutoff value for CEA level of 5 ng/mL, sensitivity was 75% and specificity 100% in the diagnosis of malignant pericarditis. Follow-up study (mean, 12.9, 19.8, and 11.8 months in groups 1, 2, and 3, respectively, showed no symptoms or signs of constrictive pericarditis, except for 1 patient.Pericardial fluid ADA and CEA are useful for the differential diagnosis of pericardial effusion of various causes. They also have great value in early diagnosis of TP, particularly when the results of other clinical and laboratory tests are negative." @default.
- W2063253927 created "2016-06-24" @default.
- W2063253927 creator A5019682489 @default.
- W2063253927 creator A5023237174 @default.
- W2063253927 creator A5030185111 @default.
- W2063253927 creator A5039358498 @default.
- W2063253927 creator A5039669586 @default.
- W2063253927 creator A5039831356 @default.
- W2063253927 creator A5044755679 @default.
- W2063253927 creator A5049017854 @default.
- W2063253927 creator A5077589712 @default.
- W2063253927 creator A5088782584 @default.
- W2063253927 date "1994-06-01" @default.
- W2063253927 modified "2023-10-03" @default.
- W2063253927 title "Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis." @default.
- W2063253927 cites W1968136629 @default.
- W2063253927 cites W1987801044 @default.
- W2063253927 cites W1999758235 @default.
- W2063253927 cites W2009896724 @default.
- W2063253927 cites W2024625672 @default.
- W2063253927 cites W2047334527 @default.
- W2063253927 cites W2048670166 @default.
- W2063253927 cites W2070687800 @default.
- W2063253927 cites W2078275520 @default.
- W2063253927 cites W2086378963 @default.
- W2063253927 cites W2105553562 @default.
- W2063253927 cites W2109976044 @default.
- W2063253927 cites W2120109456 @default.
- W2063253927 cites W2137564830 @default.
- W2063253927 cites W2147783110 @default.
- W2063253927 cites W2177063286 @default.
- W2063253927 cites W2376958329 @default.
- W2063253927 cites W4236928373 @default.
- W2063253927 cites W4244416476 @default.
- W2063253927 cites W4294116109 @default.
- W2063253927 doi "https://doi.org/10.1161/01.cir.89.6.2728" @default.
- W2063253927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8205688" @default.
- W2063253927 hasPublicationYear "1994" @default.
- W2063253927 type Work @default.
- W2063253927 sameAs 2063253927 @default.
- W2063253927 citedByCount "112" @default.
- W2063253927 countsByYear W20632539272012 @default.
- W2063253927 countsByYear W20632539272013 @default.
- W2063253927 countsByYear W20632539272014 @default.
- W2063253927 countsByYear W20632539272015 @default.
- W2063253927 countsByYear W20632539272016 @default.
- W2063253927 countsByYear W20632539272017 @default.
- W2063253927 countsByYear W20632539272019 @default.
- W2063253927 countsByYear W20632539272020 @default.
- W2063253927 countsByYear W20632539272021 @default.
- W2063253927 countsByYear W20632539272023 @default.
- W2063253927 crossrefType "journal-article" @default.
- W2063253927 hasAuthorship W2063253927A5019682489 @default.
- W2063253927 hasAuthorship W2063253927A5023237174 @default.
- W2063253927 hasAuthorship W2063253927A5030185111 @default.
- W2063253927 hasAuthorship W2063253927A5039358498 @default.
- W2063253927 hasAuthorship W2063253927A5039669586 @default.
- W2063253927 hasAuthorship W2063253927A5039831356 @default.
- W2063253927 hasAuthorship W2063253927A5044755679 @default.
- W2063253927 hasAuthorship W2063253927A5049017854 @default.
- W2063253927 hasAuthorship W2063253927A5077589712 @default.
- W2063253927 hasAuthorship W2063253927A5088782584 @default.
- W2063253927 hasBestOaLocation W20632539271 @default.
- W2063253927 hasConcept C121608353 @default.
- W2063253927 hasConcept C126322002 @default.
- W2063253927 hasConcept C141071460 @default.
- W2063253927 hasConcept C142724271 @default.
- W2063253927 hasConcept C2775934546 @default.
- W2063253927 hasConcept C2776967927 @default.
- W2063253927 hasConcept C2776991684 @default.
- W2063253927 hasConcept C2777387746 @default.
- W2063253927 hasConcept C2778005868 @default.
- W2063253927 hasConcept C2779827179 @default.
- W2063253927 hasConcept C2780459521 @default.
- W2063253927 hasConcept C2780640714 @default.
- W2063253927 hasConcept C2781001862 @default.
- W2063253927 hasConcept C2781069245 @default.
- W2063253927 hasConcept C2781175549 @default.
- W2063253927 hasConcept C2781269394 @default.
- W2063253927 hasConcept C34628245 @default.
- W2063253927 hasConcept C71924100 @default.
- W2063253927 hasConcept C90924648 @default.
- W2063253927 hasConceptScore W2063253927C121608353 @default.
- W2063253927 hasConceptScore W2063253927C126322002 @default.
- W2063253927 hasConceptScore W2063253927C141071460 @default.
- W2063253927 hasConceptScore W2063253927C142724271 @default.
- W2063253927 hasConceptScore W2063253927C2775934546 @default.
- W2063253927 hasConceptScore W2063253927C2776967927 @default.
- W2063253927 hasConceptScore W2063253927C2776991684 @default.
- W2063253927 hasConceptScore W2063253927C2777387746 @default.
- W2063253927 hasConceptScore W2063253927C2778005868 @default.
- W2063253927 hasConceptScore W2063253927C2779827179 @default.
- W2063253927 hasConceptScore W2063253927C2780459521 @default.
- W2063253927 hasConceptScore W2063253927C2780640714 @default.
- W2063253927 hasConceptScore W2063253927C2781001862 @default.
- W2063253927 hasConceptScore W2063253927C2781069245 @default.
- W2063253927 hasConceptScore W2063253927C2781175549 @default.
- W2063253927 hasConceptScore W2063253927C2781269394 @default.